ROSS HENDRICKS: Open Payments
NPI 1902272339 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 19 payments from 8 companies in 2025. Trend: 2023 $572 · 2024 $572 · 2025 $731
Food & beverage: $659Education: $72
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 9 | $259 |
| GENZYME CORPORATION | 1 | $149 |
| Organon LLC | 2 | $112 |
| ABBVIE INC. | 3 | $77 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $72 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: OPZELURA, VTAMA, BOTOX, DUPIXENT, Zoryve, COSENTYX.
Industry payments across AL — which companies pay providers there.
